BURDEN OF GLUCOCORTICOIDS AMONG RHEUMATOID ARTHRITIS PATIENTS AT DIFFERENT STAGES OF DISEASE-MODIFYING ANTIRHEUMATIC DRUG MANAGEMENT

被引：0
|
作者：
Dore, R. K.
Antonova, J. [1 ]
Gorritz, M. [2 ]
Chang, L. [1 ]
Xie, H. [2 ]
Genovese, M. C. [3 ]
机构：
[1] Gilead Sci Inc, Foster City, CA USA
[2] IQVIA, Plymouth Meeting, PA USA
[3] Stanford Univ, Div Rheumatol & Immunol, Stanford, CA 94305 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3776
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1143
引用
收藏
页码：1857 / 1858
页数：2
相关论文
共 50 条
  • [1] Disease-Modifying Antirheumatic Drug Initiation Among Patients Newly Diagnosed With Rheumatoid Arthritis
    Bonafede, Machaon
    Johnson, Barbara H.
    Shah, Neel
    Harrison, David J.
    Tang, Derek
    Stolshek, Bradley S.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (08): : SP279 - +
  • [2] Disease-Modifying Antirheumatic Drug Use and Toxicities Among Elderly Patients with Rheumatoid Arthritis.
    Manno, Rebecca L.
    Pappas, Dimitrios A.
    Saunders, Katherine C.
    Reed, George
    Grant, Shannon
    Bingham, Clifton O., III
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1046 - S1046
  • [3] VALUES UNDERLYING DISEASE-MODIFYING ANTIRHEUMATIC DRUG PREFERENCES OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Mathijssen, E.
    Vriezekolk, J.
    van den Bemt, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1802 - 1802
  • [4] IMPACT OF CORTICOSTEROID UTILIZATION ON BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG INITIATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Spivey, C. A.
    Griffith, J.
    Kaplan, C.
    Postlethwaite, A.
    Ganguli, A.
    Wang, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1503 - 1503
  • [5] Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient
    Ranganath, VK
    Furst, DE
    [J]. CLINICS IN GERIATRIC MEDICINE, 2005, 21 (03) : 649 - +
  • [6] Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient
    Ranganath, Veena K.
    Furst, Daniel E.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2007, 33 (01) : 197 - +
  • [7] Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
    Emery, Paul
    Sebba, Anthony
    Huizinga, Tom W. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : 1897 - 1904
  • [8] Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis
    Boytsov, Natalie N.
    Bhattacharya, Ritupurna
    Saverno, Kim
    Dixon, Laurin
    Abbott, Paul L.
    Zhang, Xiang
    Gaich, Carol L.
    Nair, Radhika
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (08): : 879 - 887
  • [9] Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis
    Katchamart, Wanruchada
    Narongroeknawin, Pongthorn
    Sukprasert, Ngamsiree
    Chanapai, Wanwisa
    Srisomnuek, Ananya
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (04) : 1291 - 1298
  • [10] Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis
    Wanruchada Katchamart
    Pongthorn Narongroeknawin
    Ngamsiree Sukprasert
    Wanwisa Chanapai
    Ananya Srisomnuek
    [J]. Clinical Rheumatology, 2021, 40 : 1291 - 1298
12345